Elis (ENXTPA:ELIS) Q3 Growth Keeps Value In Focus After Outlook Was Reaffirmed
Elis (ENXTPA:ELIS) reported Q3 2026 revenue growth of 6.1%, supported by 3.5% organic expansion. The company confirmed its full-year margin objectives and highlighted contributions from recent acquisitions across several regions.
Elis shares trade at €22.74 after a 1-day share price return of 2.71% and a 7-day gain of 4.22%, while the 90-day share price return is down 8.23%. That mix indicates improving short term momentum following a weaker recent stretch, alongside a 1-year total shareholder return decline of 4.91% and 3-year and 5-year total shareholder returns of 51.51% and 53.81%, which show a meaningfully stronger longer run record.
Scan how Elis compares to other potential rebound candidates by checking a curated list of 199 high quality undervalued stocks with improving business momentum.
Elis now trades at a clear discount to both analyst targets and intrinsic estimates after a fresh operational update that sounded constructive. Is the market being prudently cautious, or is it mispricing that improving momentum?
Most Popular Narrative: 24% Undervalued
Elis shares last closed at €22.74, while the most followed narrative framework arrives at a fair value of €29.96 using a 7.7% discount rate. That gap reflects a view that the current price does not fully reflect the cash flow profile and contract pipeline outlined by analysts.
Productivity gains from operational efficiency measures, including layered energy hedging that is expected to reduce the total gas and electricity bill by about €20m in 2026 versus 2025 and prior savings of about €70m across 2024 and 2025, support EBITDA margin resilience and earnings.
See why 3 investors see Elis as 24% undervalued.
Result: Fair Value of €29.96 (UNDERVALUED)
Still, two pressure points could quickly chip away at that upside case for Elis if they worsen: Latin American wage inflation and tougher healthcare contract renewals.
Find out about the key risks to this Elis narrative.
Next Steps
Mixed signals around Elis can feel noisy, so move quickly from headline takes to your own evidence based view by weighing the 5 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Elis?
If you stop with just one stock, you risk missing other opportunities that better fit your style, risk comfort and income needs right now.
- Target potential mispricing by reviewing the 199 high quality undervalued stocks that combine solid fundamentals with room for sentiment to catch up.
- Strengthen your income stream by scanning the 221 dividend fortresses that focus on higher yields supported by underlying financials.
- Dial down risk by filtering for the 222 resilient stocks with low risk scores that pair resilient balance sheets with more stable business profiles.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com